---
title: "J.P. Morgan Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295571153.md"
description: "J.P. Morgan analyst Chris Cooper maintained a Buy rating on Resmed Inc CHESS Depositary Interests (RMD), setting a price target of A$36.50, while shares closed at A$30.09. This follows other recent ratings, including a Buy from UBS and a Hold from Citi."
datetime: "2026-08-11T19:25:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295571153.md)
  - [en](https://longbridge.com/en/news/295571153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295571153.md)
generator: "portal-rs"
---

# J.P. Morgan Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)

In a report released yesterday, Chris Cooper from J.P. Morgan maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, with a price target of A$36.50. The company’s shares closed today at A$30.09.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Cooper covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Pro Medicus Limited, and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh. According to TipRanks, Cooper has an average return of 10.4% and a 65.42% success rate on recommended stocks. 

In addition to J.P. Morgan, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh also received a Buy from UBS’s David Low in a report issued on August 7. However, on August 9, Citi maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: RMD).

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [FPH.AU](https://longbridge.com/en/quote/FPH.AU.md)
- [PME.AU](https://longbridge.com/en/quote/PME.AU.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [ResMed (RMD) Q4 2026 Earnings Call Transcript](https://longbridge.com/en/news/295950697.md)
- [Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor | RMD Stock News](https://longbridge.com/en/news/296141733.md)
- [Ord Minnett Sticks to Its Buy Rating for Megaport (MGPPF)](https://longbridge.com/en/news/296725946.md)
- [Ord Minnett Sticks to Their Buy Rating for Stanmore Resources Ltd (SMR)](https://longbridge.com/en/news/296848577.md)
- [Ord Minnett Sticks to Their Buy Rating for Breville Group  (BVILF)](https://longbridge.com/en/news/296432479.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**